---
title: "Vaxcyte, Inc. (PCVX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PCVX.US.md"
symbol: "PCVX.US"
name: "Vaxcyte, Inc."
industry: "Biotechnology"
---

# Vaxcyte, Inc. (PCVX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [vaxcyte.com](https://vaxcyte.com) |

## Company Profile

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of in...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -11.82 | 468/605 | - | - | - |
| PB | 2.68 | 212/605 | 2.24 | 1.51 | 1.33 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-12T05:00:00.000Z

Total Analysts: **11**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 9 | 82% |
| Overweight | 1 | 9% |
| Hold | 1 | 9% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 54.10 |
| Highest Target | 163.00 |
| Lowest Target | 38.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/PCVX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PCVX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PCVX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.